Ellen Kuhl named director of Stanford Bio-X
March 29, 2024 - Stanford News
Kuhl aims to continue Bio-X’s legacy of facilitating multidisciplinary fundamental research and innovation.
Stanford Bio-X affiliated faculty members and fellows are generating scientific advances that expand our understanding of how the body works and will ultimately improve human health. These news stories and press releases describe some of those breakthroughs.
March 29, 2024 - Stanford News
Kuhl aims to continue Bio-X’s legacy of facilitating multidisciplinary fundamental research and innovation.
March 18, 2019 - Stanford Medicine Scope
Scientists studying cell death, including Stanford Bio-X affiliated faculty Jan Carette and Scott Dixon, are working to understand how the body protects itself from disease and use that information to form better treatments.
March 15, 2019 - Stanford News
Stanford Bio-X affiliated faculty Jennifer Dionne redefines what it means for low-cost semiconductors, called quantum dots, to be near-perfect and meet quality standards.
March 14, 2019 - Stanford Engineering
Through biometric tracking, simulated modeling and medical imaging, Stanford Bio-X affiliated faculty David Camarillo, Michael Zeineh and Gerald Grant and Stanford Bio-X Fellow Fidel Hernandez show how hits to the side of the head could cause concussions.
March 14, 2019 - Stanford Medicine News Center
Researchers under Stanford Bio-X affiliated faculty Joseph Wu have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.
March 13, 2019 - Stanford Medicine News Center
Some breast cancers return decades later. Stanford Bio-X affiliated faculty Christina Curtis, joined by collaborators at other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.
March 12, 2019 - Stanford Medicine News Center
Stanford Bio-X affiliated faculty Marion Buckwalter, Nima Aghaeepour, Martin Angst, and Maarten Lansberg have found that transient changes in circulating immune cell types can predict the likelihood of dementia one year after a stroke.
March 12, 2019 - Stanford Medicine News Center
Researchers including Stanford Bio-X affiliated faculty Michael Snyder, Karl Sylvester, David Stevenson and Tina Cowan plan to study thousands of metabolites in babies, children and pregnant women to understand the origins of disease.
March 11, 2019 - Stanford Medicine Scope
Stanford Bio-X affiliated faculty Desiree LaBeaud finds that pneumonia vaccines seem to work better if their mothers are treated for parasitic infections during pregnancy.
March 11, 2019 - Stanford Earth Matters
Stanford Bio-X affiliated faculty member Stephen Luby is on a quest to save lives by cleaning up production of a ubiquitous building material.
March 7, 2019 - Stanford News
A February 21 launch was the culmination of years of work by Stanford Bio-X Fellow Yonatan Winetraub’s nonprofit SpaceIL, which he co-founded in 2011.
March 6, 2019 - Stanford News
Stanford Bio-X affiliated faculty Dennis Wall's group is working on a smartphone app that could help diagnose autism in minutes – and provide ongoing therapy as well.
March 6, 2019 - Stanford Medicine Scope
Stanford Bio-X affiliated faculty member Sean Mackey and other researchers say we can curb the prescription opioid crisis, while treating pain, by using a variety of tactics.
March 5, 2019 - Stanford Medicine Scope
A phase 1 clinical trial by Stanford Bio-X affiliated faculty Irv Weissman, Mark Pegram, and Ravindra Majeti, of an antibody against the “don‘t eat me’ signal on cancer cells, appears safe and well-tolerated by patients with advanced cancers.
February 19, 2019 - Stanford News
Computers have shrunk, but engineers want to cram the features of a computer into a single chip that they could install anywhere. A team under Stanford Bio-X affiliated faculty Subhasish Mitra and H.-S. Philip Wong has developed the prototype.
February 18, 2019 - Stanford Medicine News Center
Life expectancy grows when there are more primary care physicians in the field, yet their numbers are shrinking, finds a study led by researchers including Stanford Bio-X affiliated faculty member Sanjay Basu.
February 14, 2019 - Stanford Engineering
A new analysis from Stanford Bio-X affiliated faculty Jure Leskovec and Marcus Feldman reveals that every species from bacteria to primates has developed ways to bypass breakdowns in the networks of proteins vital to sustaining life.
February 14, 2019 - Stanford Medicine Scope
More than a third of patients who are prescribed statins fail to take them regularly, and they are dying at higher rates as a result, according to research from Stanford Bio-X affiliated faculty member Joshua Knowles.
February 13, 2019 - Stanford Medicine Scope
Medical residents spend more than five hours a shift in front of computer screens, much of it reviewing notes, Stanford research from Stanford Bio-X affiliated faculty member Jonathan Chen has found.
February 13, 2019 - Stanford Medicine Scope
Scientists including Stanford Bio-X affiliated faculty member James Zou have created an algorithm that works to generate and refine DNA sequences that are likely to code for antimicrobial proteins.
February 4, 2019 - Stanford Medicine News Center
In rheumatoid arthritis, helper T cells behave differently from regular cells. Stanford Bio-X affiliated faculty members Cornelia Weyand and Jorg Goronzy have learned why.
January 31, 2019 - Stanford Medicine News Center
The discovery, by researchers under Stanford Bio-X affiliated faculty member Nirao Shah, of neurons that drive mice’s innate ability to identify the sex of other mice highlights the importance of biological influences on sex-specific behaviors.
January 8, 2019
The Stanford Bio-X Leadership Council is pleased to announce the 16th annual competition for Stanford Bio-X Graduate Student Fellowships.
December 20, 2018
Developing drugs is typically the domain of large pharmaceutical companies. Felix and Heather Baker Interdisciplinary Graduate Fellow and Stanford Bio-X SIGF Teresa Purzner shares an example of drug development for a rare pediatric brain cancer that was done in a university setting.
December 6, 2018 - Stanford Medicine News Center
Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, as found in research by Stanford Bio-X affiliated faculty members Michelle Monje, Erin Gibson, and Hannes Vogel, with co-authors Stanford Bio-X Genentech Fellow Anna Geraghty, and Stanford Bio-X Undergraduate Summer Research Program participants Andra Goldstein, Jacob Greene, Alfonso Ocampo, Lydia Tam, and Praveen Pallegar.
November 29, 2018 - Stanford News
A particularly deadly form of ovarian cancer is so deadly in part because it is quick to develop resistance to the drugs used to treat it. With support from a Stanford Bio-X Seed Grant, Stanford Bio-X affiliated faculty members Erinn Rankin, Sarah Heilshorn, and Oliver Dorigo are using new materials and imaging techniques to better understand the disease.
November 5, 2018
The Stanford Bio-X Program and the Novo Nordisk Foundation would like to announce our call for applications for the Visiting Scholar or Postdoc Fellowships @ Stanford Bio-X!
October 12, 2018 - Stanford News
A new computer model from Stanford Bio-X affiliated faculty member Ellen Kuhl maps how misshapen proteins associated with Alzheimer’s and Parkinson’s diseases and ALS spread throughout the brain. The work, supported by a Stanford Bio-X IIP Seed Grant, could aid in finding ways to diagnose and treat these neurodegenerative disorders.
October 10, 2018
The Stanford Bio-X Program would like to announce our call for applications for the Undergraduate Summer Research Program with funding available starting in the summer of 2018.
July 26, 2018 - Stanford Medicine News Center
A new genetic screen may be able to predict low bone-mineral density, osteoporosis and fracture risk prior to clinical symptoms, according to a retrospective study of nearly 400,000 people by Stanford Bio-X affiliated faculty member Stuart Kim.
July 26, 2018 - Stanford Medicine News Center
A molecule called propionate inhibits the growth of Salmonella in mice and may be a promising treatment, say Stanford Bio-X affiliates Denise Monack, José Vilches-Moure, Justin Sonnenburg, Ami Bhatt, and KC Huang, and Travel Awardee Amanda Jacobson.